img

Global Menopause Hormonal Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Menopause Hormonal Drug Market Insights, Forecast to 2034

Global Menopause Hormonal Drug market is expected to reach to US$ 13800 million in 2024, with a positive growth of %, compared with US$ 13210 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Menopause Hormonal Drug industry is evaluated to reach US$ 18930 million in 2029. The CAGR will be 5.4% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Menopause Hormonal Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Menopause Hormonal Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Novartis
Novo Nordisk
Pfizer
Allergan
Emcure Pharmaceuticals
Eli Lilly And Company
Bayer
Theramex
AbbVie
Segment by Type
Table
Gel
Spray
Others

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Menopause Hormonal Drug plant distribution, commercial date of Menopause Hormonal Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Menopause Hormonal Drug introduction, etc. Menopause Hormonal Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Menopause Hormonal Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Menopause Hormonal Drug Product Introduction
1.2 Market by Type
1.2.1 Global Menopause Hormonal Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Table
1.2.3 Gel
1.2.4 Spray
1.2.5 Others
1.3 Market by Application
1.3.1 Global Menopause Hormonal Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Menopause Hormonal Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Menopause Hormonal Drug Revenue by Region
2.2.1 Global Menopause Hormonal Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Menopause Hormonal Drug Revenue by Region (2018-2024)
2.2.3 Global Menopause Hormonal Drug Revenue by Region (2024-2029)
2.2.4 Global Menopause Hormonal Drug Revenue Market Share by Region (2018-2029)
2.3 Global Menopause Hormonal Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Menopause Hormonal Drug Sales by Region
2.4.1 Global Menopause Hormonal Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Menopause Hormonal Drug Sales by Region (2018-2024)
2.4.3 Global Menopause Hormonal Drug Sales by Region (2024-2029)
2.4.4 Global Menopause Hormonal Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Menopause Hormonal Drug Sales by Manufacturers
3.1.1 Global Menopause Hormonal Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Menopause Hormonal Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Menopause Hormonal Drug in 2022
3.2 Global Menopause Hormonal Drug Revenue by Manufacturers
3.2.1 Global Menopause Hormonal Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Menopause Hormonal Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Menopause Hormonal Drug Revenue in 2022
3.3 Global Key Players of Menopause Hormonal Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Menopause Hormonal Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Menopause Hormonal Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Menopause Hormonal Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Menopause Hormonal Drug, Product Offered and Application
3.8 Global Key Manufacturers of Menopause Hormonal Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Menopause Hormonal Drug Sales by Type
4.1.1 Global Menopause Hormonal Drug Historical Sales by Type (2018-2024)
4.1.2 Global Menopause Hormonal Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Menopause Hormonal Drug Sales Market Share by Type (2018-2029)
4.2 Global Menopause Hormonal Drug Revenue by Type
4.2.1 Global Menopause Hormonal Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Menopause Hormonal Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Menopause Hormonal Drug Revenue Market Share by Type (2018-2029)
4.3 Global Menopause Hormonal Drug Price by Type
4.3.1 Global Menopause Hormonal Drug Price by Type (2018-2024)
4.3.2 Global Menopause Hormonal Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Menopause Hormonal Drug Sales by Application
5.1.1 Global Menopause Hormonal Drug Historical Sales by Application (2018-2024)
5.1.2 Global Menopause Hormonal Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Menopause Hormonal Drug Sales Market Share by Application (2018-2029)
5.2 Global Menopause Hormonal Drug Revenue by Application
5.2.1 Global Menopause Hormonal Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Menopause Hormonal Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Menopause Hormonal Drug Revenue Market Share by Application (2018-2029)
5.3 Global Menopause Hormonal Drug Price by Application
5.3.1 Global Menopause Hormonal Drug Price by Application (2018-2024)
5.3.2 Global Menopause Hormonal Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Menopause Hormonal Drug Market Size by Type
6.1.1 US & Canada Menopause Hormonal Drug Sales by Type (2018-2029)
6.1.2 US & Canada Menopause Hormonal Drug Revenue by Type (2018-2029)
6.2 US & Canada Menopause Hormonal Drug Market Size by Application
6.2.1 US & Canada Menopause Hormonal Drug Sales by Application (2018-2029)
6.2.2 US & Canada Menopause Hormonal Drug Revenue by Application (2018-2029)
6.3 US & Canada Menopause Hormonal Drug Market Size by Country
6.3.1 US & Canada Menopause Hormonal Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Menopause Hormonal Drug Sales by Country (2018-2029)
6.3.3 US & Canada Menopause Hormonal Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Menopause Hormonal Drug Market Size by Type
7.1.1 Europe Menopause Hormonal Drug Sales by Type (2018-2029)
7.1.2 Europe Menopause Hormonal Drug Revenue by Type (2018-2029)
7.2 Europe Menopause Hormonal Drug Market Size by Application
7.2.1 Europe Menopause Hormonal Drug Sales by Application (2018-2029)
7.2.2 Europe Menopause Hormonal Drug Revenue by Application (2018-2029)
7.3 Europe Menopause Hormonal Drug Market Size by Country
7.3.1 Europe Menopause Hormonal Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Menopause Hormonal Drug Sales by Country (2018-2029)
7.3.3 Europe Menopause Hormonal Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Menopause Hormonal Drug Market Size
8.1.1 China Menopause Hormonal Drug Sales (2018-2029)
8.1.2 China Menopause Hormonal Drug Revenue (2018-2029)
8.2 China Menopause Hormonal Drug Market Size by Application
8.2.1 China Menopause Hormonal Drug Sales by Application (2018-2029)
8.2.2 China Menopause Hormonal Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Menopause Hormonal Drug Market Size by Type
9.1.1 Asia Menopause Hormonal Drug Sales by Type (2018-2029)
9.1.2 Asia Menopause Hormonal Drug Revenue by Type (2018-2029)
9.2 Asia Menopause Hormonal Drug Market Size by Application
9.2.1 Asia Menopause Hormonal Drug Sales by Application (2018-2029)
9.2.2 Asia Menopause Hormonal Drug Revenue by Application (2018-2029)
9.3 Asia Menopause Hormonal Drug Sales by Region
9.3.1 Asia Menopause Hormonal Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Menopause Hormonal Drug Revenue by Region (2018-2029)
9.3.3 Asia Menopause Hormonal Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Menopause Hormonal Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Menopause Hormonal Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Menopause Hormonal Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Menopause Hormonal Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Menopause Hormonal Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Menopause Hormonal Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Menopause Hormonal Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Menopause Hormonal Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Menopause Hormonal Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Menopause Hormonal Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Menopause Hormonal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Merck Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Overview
11.2.3 Novartis Menopause Hormonal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Novartis Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Overview
11.3.3 Novo Nordisk Menopause Hormonal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novo Nordisk Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novo Nordisk Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Menopause Hormonal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Pfizer Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Allergan
11.5.1 Allergan Company Information
11.5.2 Allergan Overview
11.5.3 Allergan Menopause Hormonal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Allergan Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Allergan Recent Developments
11.6 Emcure Pharmaceuticals
11.6.1 Emcure Pharmaceuticals Company Information
11.6.2 Emcure Pharmaceuticals Overview
11.6.3 Emcure Pharmaceuticals Menopause Hormonal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Emcure Pharmaceuticals Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Emcure Pharmaceuticals Recent Developments
11.7 Eli Lilly And Company
11.7.1 Eli Lilly And Company Company Information
11.7.2 Eli Lilly And Company Overview
11.7.3 Eli Lilly And Company Menopause Hormonal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Eli Lilly And Company Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Eli Lilly And Company Recent Developments
11.8 Bayer
11.8.1 Bayer Company Information
11.8.2 Bayer Overview
11.8.3 Bayer Menopause Hormonal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Bayer Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bayer Recent Developments
11.9 Theramex
11.9.1 Theramex Company Information
11.9.2 Theramex Overview
11.9.3 Theramex Menopause Hormonal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Theramex Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Theramex Recent Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Overview
11.10.3 AbbVie Menopause Hormonal Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 AbbVie Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AbbVie Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Menopause Hormonal Drug Industry Chain Analysis
12.2 Menopause Hormonal Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Menopause Hormonal Drug Production Mode & Process
12.4 Menopause Hormonal Drug Sales and Marketing
12.4.1 Menopause Hormonal Drug Sales Channels
12.4.2 Menopause Hormonal Drug Distributors
12.5 Menopause Hormonal Drug Customers
13 Market Dynamics
13.1 Menopause Hormonal Drug Industry Trends
13.2 Menopause Hormonal Drug Market Drivers
13.3 Menopause Hormonal Drug Market Challenges
13.4 Menopause Hormonal Drug Market Restraints
14 Key Findings in The Global Menopause Hormonal Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Menopause Hormonal Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Table
Table 3. Major Manufacturers of Gel
Table 4. Major Manufacturers of Spray
Table 5. Major Manufacturers of Others
Table 6. Global Menopause Hormonal Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Menopause Hormonal Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Menopause Hormonal Drug Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Menopause Hormonal Drug Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Menopause Hormonal Drug Revenue Market Share by Region (2018-2024)
Table 11. Global Menopause Hormonal Drug Revenue Market Share by Region (2024-2029)
Table 12. Global Menopause Hormonal Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Menopause Hormonal Drug Sales by Region (2018-2024) & (Tons)
Table 14. Global Menopause Hormonal Drug Sales by Region (2024-2029) & (Tons)
Table 15. Global Menopause Hormonal Drug Sales Market Share by Region (2018-2024)
Table 16. Global Menopause Hormonal Drug Sales Market Share by Region (2024-2029)
Table 17. Global Menopause Hormonal Drug Sales by Manufacturers (2018-2024) & (Tons)
Table 18. Global Menopause Hormonal Drug Sales Share by Manufacturers (2018-2024)
Table 19. Global Menopause Hormonal Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Menopause Hormonal Drug Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Menopause Hormonal Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Menopause Hormonal Drug Price by Manufacturers 2018-2024 (US$/Ton)
Table 23. Global Menopause Hormonal Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Menopause Hormonal Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopause Hormonal Drug as of 2022)
Table 25. Global Key Manufacturers of Menopause Hormonal Drug, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Menopause Hormonal Drug, Product Offered and Application
Table 27. Global Key Manufacturers of Menopause Hormonal Drug, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Menopause Hormonal Drug Sales by Type (2018-2024) & (Tons)
Table 30. Global Menopause Hormonal Drug Sales by Type (2024-2029) & (Tons)
Table 31. Global Menopause Hormonal Drug Sales Share by Type (2018-2024)
Table 32. Global Menopause Hormonal Drug Sales Share by Type (2024-2029)
Table 33. Global Menopause Hormonal Drug Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Menopause Hormonal Drug Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Menopause Hormonal Drug Revenue Share by Type (2018-2024)
Table 36. Global Menopause Hormonal Drug Revenue Share by Type (2024-2029)
Table 37. Menopause Hormonal Drug Price by Type (2018-2024) & (US$/Ton)
Table 38. Global Menopause Hormonal Drug Price Forecast by Type (2024-2029) & (US$/Ton)
Table 39. Global Menopause Hormonal Drug Sales by Application (2018-2024) & (Tons)
Table 40. Global Menopause Hormonal Drug Sales by Application (2024-2029) & (Tons)
Table 41. Global Menopause Hormonal Drug Sales Share by Application (2018-2024)
Table 42. Global Menopause Hormonal Drug Sales Share by Application (2024-2029)
Table 43. Global Menopause Hormonal Drug Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Menopause Hormonal Drug Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Menopause Hormonal Drug Revenue Share by Application (2018-2024)
Table 46. Global Menopause Hormonal Drug Revenue Share by Application (2024-2029)
Table 47. Menopause Hormonal Drug Price by Application (2018-2024) & (US$/Ton)
Table 48. Global Menopause Hormonal Drug Price Forecast by Application (2024-2029) & (US$/Ton)
Table 49. US & Canada Menopause Hormonal Drug Sales by Type (2018-2024) & (Tons)
Table 50. US & Canada Menopause Hormonal Drug Sales by Type (2024-2029) & (Tons)
Table 51. US & Canada Menopause Hormonal Drug Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Menopause Hormonal Drug Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Menopause Hormonal Drug Sales by Application (2018-2024) & (Tons)
Table 54. US & Canada Menopause Hormonal Drug Sales by Application (2024-2029) & (Tons)
Table 55. US & Canada Menopause Hormonal Drug Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Menopause Hormonal Drug Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Menopause Hormonal Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Menopause Hormonal Drug Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Menopause Hormonal Drug Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Menopause Hormonal Drug Sales by Country (2018-2024) & (Tons)
Table 61. US & Canada Menopause Hormonal Drug Sales by Country (2024-2029) & (Tons)
Table 62. Europe Menopause Hormonal Drug Sales by Type (2018-2024) & (Tons)
Table 63. Europe Menopause Hormonal Drug Sales by Type (2024-2029) & (Tons)
Table 64. Europe Menopause Hormonal Drug Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Menopause Hormonal Drug Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Menopause Hormonal Drug Sales by Application (2018-2024) & (Tons)
Table 67. Europe Menopause Hormonal Drug Sales by Application (2024-2029) & (Tons)
Table 68. Europe Menopause Hormonal Drug Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Menopause Hormonal Drug Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Menopause Hormonal Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Menopause Hormonal Drug Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Menopause Hormonal Drug Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Menopause Hormonal Drug Sales by Country (2018-2024) & (Tons)
Table 74. Europe Menopause Hormonal Drug Sales by Country (2024-2029) & (Tons)
Table 75. China Menopause Hormonal Drug Sales by Type (2018-2024) & (Tons)
Table 76. China Menopause Hormonal Drug Sales by Type (2024-2029) & (Tons)
Table 77. China Menopause Hormonal Drug Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Menopause Hormonal Drug Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Menopause Hormonal Drug Sales by Application (2018-2024) & (Tons)
Table 80. China Menopause Hormonal Drug Sales by Application (2024-2029) & (Tons)
Table 81. China Menopause Hormonal Drug Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Menopause Hormonal Drug Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Menopause Hormonal Drug Sales by Type (2018-2024) & (Tons)
Table 84. Asia Menopause Hormonal Drug Sales by Type (2024-2029) & (Tons)
Table 85. Asia Menopause Hormonal Drug Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Menopause Hormonal Drug Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Menopause Hormonal Drug Sales by Application (2018-2024) & (Tons)
Table 88. Asia Menopause Hormonal Drug Sales by Application (2024-2029) & (Tons)
Table 89. Asia Menopause Hormonal Drug Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Menopause Hormonal Drug Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Menopause Hormonal Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Menopause Hormonal Drug Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Menopause Hormonal Drug Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Menopause Hormonal Drug Sales by Region (2018-2024) & (Tons)
Table 95. Asia Menopause Hormonal Drug Sales by Region (2024-2029) & (Tons)
Table 96. Middle East, Africa and Latin America Menopause Hormonal Drug Sales by Type (2018-2024) & (Tons)
Table 97. Middle East, Africa and Latin America Menopause Hormonal Drug Sales by Type (2024-2029) & (Tons)
Table 98. Middle East, Africa and Latin America Menopause Hormonal Drug Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Menopause Hormonal Drug Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Menopause Hormonal Drug Sales by Application (2018-2024) & (Tons)
Table 101. Middle East, Africa and Latin America Menopause Hormonal Drug Sales by Application (2024-2029) & (Tons)
Table 102. Middle East, Africa and Latin America Menopause Hormonal Drug Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Menopause Hormonal Drug Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Menopause Hormonal Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Menopause Hormonal Drug Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Menopause Hormonal Drug Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Menopause Hormonal Drug Sales by Country (2018-2024) & (Tons)
Table 108. Middle East, Africa and Latin America Menopause Hormonal Drug Sales by Country (2024-2029) & (Tons)
Table 109. Merck Company Information
Table 110. Merck Description and Major Businesses
Table 111. Merck Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 112. Merck Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Merck Recent Developments
Table 114. Novartis Company Information
Table 115. Novartis Description and Major Businesses
Table 116. Novartis Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 117. Novartis Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Novartis Recent Developments
Table 119. Novo Nordisk Company Information
Table 120. Novo Nordisk Description and Major Businesses
Table 121. Novo Nordisk Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 122. Novo Nordisk Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Novo Nordisk Recent Developments
Table 124. Pfizer Company Information
Table 125. Pfizer Description and Major Businesses
Table 126. Pfizer Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 127. Pfizer Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Pfizer Recent Developments
Table 129. Allergan Company Information
Table 130. Allergan Description and Major Businesses
Table 131. Allergan Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 132. Allergan Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Allergan Recent Developments
Table 134. Emcure Pharmaceuticals Company Information
Table 135. Emcure Pharmaceuticals Description and Major Businesses
Table 136. Emcure Pharmaceuticals Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 137. Emcure Pharmaceuticals Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Emcure Pharmaceuticals Recent Developments
Table 139. Eli Lilly And Company Company Information
Table 140. Eli Lilly And Company Description and Major Businesses
Table 141. Eli Lilly And Company Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 142. Eli Lilly And Company Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Eli Lilly And Company Recent Developments
Table 144. Bayer Company Information
Table 145. Bayer Description and Major Businesses
Table 146. Bayer Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 147. Bayer Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Bayer Recent Developments
Table 149. Theramex Company Information
Table 150. Theramex Description and Major Businesses
Table 151. Theramex Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 152. Theramex Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Theramex Recent Developments
Table 154. AbbVie Company Information
Table 155. AbbVie Description and Major Businesses
Table 156. AbbVie Menopause Hormonal Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 157. AbbVie Menopause Hormonal Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. AbbVie Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Menopause Hormonal Drug Distributors List
Table 162. Menopause Hormonal Drug Customers List
Table 163. Menopause Hormonal Drug Market Trends
Table 164. Menopause Hormonal Drug Market Drivers
Table 165. Menopause Hormonal Drug Market Challenges
Table 166. Menopause Hormonal Drug Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Menopause Hormonal Drug Product Picture
Figure 2. Global Menopause Hormonal Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Menopause Hormonal Drug Market Share by Type in 2022 & 2029
Figure 4. Table Product Picture
Figure 5. Gel Product Picture
Figure 6. Spray Product Picture
Figure 7. Others Product Picture
Figure 8. Global Menopause Hormonal Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Menopause Hormonal Drug Market Share by Application in 2022 & 2029
Figure 10. Hospital Pharmacies
Figure 11. Retail Pharmacies
Figure 12. Online Pharmacies
Figure 13. Menopause Hormonal Drug Report Years Considered
Figure 14. Global Menopause Hormonal Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Menopause Hormonal Drug Revenue 2018-2029 (US$ Million)
Figure 16. Global Menopause Hormonal Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Menopause Hormonal Drug Revenue Market Share by Region (2018-2029)
Figure 18. Global Menopause Hormonal Drug Sales 2018-2029 ((Tons)
Figure 19. Global Menopause Hormonal Drug Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Menopause Hormonal Drug Sales YoY (2018-2029) & (Tons)
Figure 21. US & Canada Menopause Hormonal Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Menopause Hormonal Drug Sales YoY (2018-2029) & (Tons)
Figure 23. Europe Menopause Hormonal Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Menopause Hormonal Drug Sales YoY (2018-2029) & (Tons)
Figure 25. China Menopause Hormonal Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Menopause Hormonal Drug Sales YoY (2018-2029) & (Tons)
Figure 27. Asia (excluding China) Menopause Hormonal Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Menopause Hormonal Drug Sales YoY (2018-2029) & (Tons)
Figure 29. Middle East, Africa and Latin America Menopause Hormonal Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Menopause Hormonal Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Menopause Hormonal Drug in the World: Market Share by Menopause Hormonal Drug Revenue in 2022
Figure 32. Global Menopause Hormonal Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Menopause Hormonal Drug Sales Market Share by Type (2018-2029)
Figure 34. Global Menopause Hormonal Drug Revenue Market Share by Type (2018-2029)
Figure 35. Global Menopause Hormonal Drug Sales Market Share by Application (2018-2029)
Figure 36. Global Menopause Hormonal Drug Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Menopause Hormonal Drug Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Menopause Hormonal Drug Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Menopause Hormonal Drug Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Menopause Hormonal Drug Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Menopause Hormonal Drug Revenue Share by Country (2018-2029)
Figure 42. US & Canada Menopause Hormonal Drug Sales Share by Country (2018-2029)
Figure 43. U.S. Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Menopause Hormonal Drug Sales Market Share by Type (2018-2029)
Figure 46. Europe Menopause Hormonal Drug Revenue Market Share by Type (2018-2029)
Figure 47. Europe Menopause Hormonal Drug Sales Market Share by Application (2018-2029)
Figure 48. Europe Menopause Hormonal Drug Revenue Market Share by Application (2018-2029)
Figure 49. Europe Menopause Hormonal Drug Revenue Share by Country (2018-2029)
Figure 50. Europe Menopause Hormonal Drug Sales Share by Country (2018-2029)
Figure 51. Germany Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 52. France Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 56. China Menopause Hormonal Drug Sales Market Share by Type (2018-2029)
Figure 57. China Menopause Hormonal Drug Revenue Market Share by Type (2018-2029)
Figure 58. China Menopause Hormonal Drug Sales Market Share by Application (2018-2029)
Figure 59. China Menopause Hormonal Drug Revenue Market Share by Application (2018-2029)
Figure 60. Asia Menopause Hormonal Drug Sales Market Share by Type (2018-2029)
Figure 61. Asia Menopause Hormonal Drug Revenue Market Share by Type (2018-2029)
Figure 62. Asia Menopause Hormonal Drug Sales Market Share by Application (2018-2029)
Figure 63. Asia Menopause Hormonal Drug Revenue Market Share by Application (2018-2029)
Figure 64. Asia Menopause Hormonal Drug Revenue Share by Region (2018-2029)
Figure 65. Asia Menopause Hormonal Drug Sales Share by Region (2018-2029)
Figure 66. Japan Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 70. India Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Menopause Hormonal Drug Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Menopause Hormonal Drug Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Menopause Hormonal Drug Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Menopause Hormonal Drug Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Menopause Hormonal Drug Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Menopause Hormonal Drug Sales Share by Country (2018-2029)
Figure 77. Brazil Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Menopause Hormonal Drug Revenue (2018-2029) & (US$ Million)
Figure 82. Menopause Hormonal Drug Value Chain
Figure 83. Menopause Hormonal Drug Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries